Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver

Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver

Inflammatory liver diseases in the absence of pathogens such as intoxication by xenobiotics, cholestatic liver injury, hepatic ischemia-reperfusion injury (I/R), non-alcoholic steatohepatitis (NASH), or alcoholic liver disease (ALD) remain threatening conditions demanding specific therapeutic option...

Full description

Bibliographic Details
Main Author:	Sabine Mihm
Format:	Article
Language:	English
Published:	MDPI AG 2018-10-01
Series:	International Journal of Molecular Sciences
Subjects:	sterile liver injury acetaminophen (APAP) intoxication cholestasis hepatic ischemia-reperfusion (I/R) non-alcoholic steatohepatitis (NASH) alcoholic liver disease (ALD) danger-associated molecular pattern (DAMP) high mobility group box-1 (HMGB1) type I interferon (IFN)
Online Access:	http://www.mdpi.com/1422-0067/19/10/3104

Similar Items

Acetaminophen-Induced Rat Hepatotoxicity Based on M1/M2-Macrophage Polarization, in Possible Relation to Damage-Associated Molecular Patterns and Autophagy
by: Yuka Tsuji, et al.
Published: (2020-11-01)

Possibilities of ademetionine in treatment of patients with alcoholic liver disease
by: L. V. Maslovskiy, et al.
Published: (2020-10-01)

Regulation of hepatic genes related to lipid metabolism and antioxidant enzymes by sodium butyrate supplementation
by: Kazue Honma, et al.
Published: (2020-09-01)

Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
by: Ralf Weiskirchen
Published: (2019-10-01)

Management of acetaminophen toxicity, a review
by: Alejandra Beltrán-Olazábal, et al.
Published: (2019-10-01)

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
by: Stephen Caldwell
Published: (2017-06-01)

Alcohol or Not: A Review Comparing Initial Mechanisms, Contributing Factors, and Liver Transplantation Outcomes Between Alcoholic and Nonalcoholic Steatohepatitis
by: Chung-Shiung Wen, et al.
Published: (2018-09-01)

Effect of Acetaminophen (APAP) on Physiological Indicators in <i>Lactuca sativa</i>
by: Jiri Kudrna, et al.
Published: (2020-11-01)

Mangiferin ameliorates acetaminophen-induced hepatotoxicity through APAP-Cys and JNK modulation
by: Apu Chowdhury, et al.
Published: (2019-09-01)

Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD – Reconciling the present with the pastKey points
by: Oyekoya T. Ayonrinde
Published: (2021-06-01)

Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation
by: Laura Micheli, et al.
Published: (2020-06-01)

Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice
by: Daniel Cabrera, et al.
Published: (2021-09-01)

Vitamins and non-alcoholic fatty liver disease: A molecular insight
by: Sana Raza, et al.
Published: (2021-06-01)

Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD
by: Victoria Svop Jensen, et al.
Published: (2021-02-01)

NAFLD: Challenges and opportunities to address the public health problem in Latin America
by: Juan Pablo Arab, et al.
Published: (2021-09-01)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010-07-01)

Commentary: The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity
by: Barbara Barbaro, et al.
Published: (2018-10-01)

Viewpoint: “Alcohol Consumption in Late Adolescence is Associated With an Increased Risk of Severe Liver Disease Later in Life”
by: Adriana Tamburello, et al.
Published: (2018-05-01)

Liver-specific deletion of mechanistic target of rapamycin does not protect against acetaminophen-induced liver injury in mice
by: Hua Sun, et al.
Published: (2021-06-01)

Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis
by: Javier Ampuero, et al.

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
by: Akinobu Takaki, et al.
Published: (2014-04-01)

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
by: Nicha Wongjarupong, et al.
Published: (2017-12-01)

Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage
by: Anna Pastore, et al.
Published: (2014-11-01)

CD36 deficiency ameliorates drug-induced acute liver injury in mice
by: Chen Zhang, et al.
Published: (2021-06-01)

Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis
by: Shui-Xian Du, et al.
Published: (2017-12-01)

Alcoholic hepatitis: How far are we and where are we going?
by: Verónica Prado, et al.
Published: (2016-07-01)

Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
by: Diren Beyoğlu, et al.
Published: (2020-01-01)

Pre-treatment twice with liposomal clodronate protects against acetaminophen hepatotoxicity through a pre-conditioning effect
by: Melissa M. Clemens, et al.
Published: (2020-09-01)

The Inhibitory T Cell Receptors PD1 and 2B4 Are Differentially Regulated on CD4 and CD8 T Cells in a Mouse Model of Non-alcoholic Steatohepatitis
by: Cordula Hansel, et al.
Published: (2019-03-01)

Combined alcoholic and non-alcoholic steatohepatitisKey points
by: Line Carolle Ntandja Wandji, et al.
Published: (2020-06-01)

Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease
by: Yang Xiao, et al.
Published: (2021-08-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
by: Clémence Rives, et al.
Published: (2020-12-01)

Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern
by: Ekta Dhamija, et al.
Published: (2019-01-01)

Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
by: Joo Ho Lee, et al.
Published: (2014-08-01)

Presence and Implications of Sarcopenia in Non-Alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis
by: Adnan Said, et al.
Published: (2017-07-01)

NASH and cryptogenic cirrhosis: A histological analysis†† Financial Support/Grants: This research supported in part by the Intramural Research Program of the NIH, National Cancer Institute.
by: Stephen H. Caldwell, et al.
Published: (2009-10-01)